Nurse-like cells control the activity of chronic lymphocytic leukemia B cells via galectin-1

Leukemia

Volumn 27, Issue 6, 2013, Pages 1413-1416

  Croci, D O ^a   Morande, P E ^b   Dergan Dylon, S ^a   Borge, M ^b   Toscano, M A ^a   Stupirski, J C ^a   Bezares, R F ^c   Avalos, J S ^d   Narbaitz, M ^b   Gamberale, R ^b   Rabinovich, G A ^a   Giordano, M ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^c HOSPITAL DURAND   (Argentina)

^d HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; B7 ANTIGEN; CD86 ANTIGEN; GALECTIN 1; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA;

ADHERENT CELL; B CELL LEUKEMIA; BONE MARROW BIOPSY; CELL TYPE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; HUMAN; HUMAN TISSUE; LETTER; LEUKEMIA CELL; MONOCYTE; NURSE LIKE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

FLOW CYTOMETRY; GALECTIN 1; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;

EID: 84878942469     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2012.315     Document Type: Letter

References (15)

1. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005; 352: 804-815.
2. Riches JC, Ramsay AG, Gribben JG. T-cell function in chronic lymphocytic leukaemia. Semin Cancer Biol 2010; 20: 431-438.
3. Abroun S, Otsuyama K, Shamsasenjan K, Islam A, Amin J, Iqbal MS et al. Galectin-1 supports the survival of CD45RA(-) primary myeloma cells in vitro. Br J Haematol 2008; 142: 754-765.
4. Rabinovich GA, Croci DO. Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer. Immunity 2012; 36: 322-335.
5. Juszczynski P, Ouyang J, Monti S, Rodig SJ, Takeyama K, Abramson J et al. The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma. Proc Natl Acad Sci USA 2007; 104: 13134-13139. (Pubitemid 351737605)
6. Burger JA, Tsukada N, Burger M, Zvaifler NJ, Dell'Aquila M, Kipps TJ. Bloodderived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood 2000; 96: 2655-2663.
7. Morande PE, Zanetti SR, Borge M, Nannini P, Jancic C, Bezares RF et al. The cytotoxic activity of Aplidin in chronic lymphocytic leukemia (CLL) is mediated by a direct effect on leukemic cells and an indirect effect on monocyte-derived cells. Invest New Drugs 2012; 30: 1830-1840.
8. Ilarregui JM, Croci DO, Bianco GA, Toscano MA, Salatino M, Vermeulen ME et al. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat Immunol 2009; 10: 981-991.
9. Fayad L, Keating MJ, Reuben JM, O'Brien S, Lee BN, Lerner S et al. Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. Blood 2001; 97: 256-263. (Pubitemid 32061268)
10. Sivina M, Hartmann E, Kipps TJ, Rassenti L, Krupnik D, Lerner S et al. CCL3 (MIP-1alpha) plasma levels and the risk for disease progression in chronic lymphocytic leukemia. Blood 2011; 117: 1662-1669.
11. Yan XJ, Dozmorov I, Li W, Yancopoulos S, Sison C, Centola M et al. Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia. Blood 2011; 118: 5201-5210.
12. Packham G, Stevenson F. The role of the B-cell receptor in the pathogenesis of chronic lymphocytic leukaemia. Semin Cancer Biol 2010; 20: 391-399.
13. Gauthier L, Rossi B, Roux F, Termine E, Schiff C. Galectin-1 is a stromal cell ligand of the pre-B cell receptor (BCR) implicated in synapse formation between pre-B and stromal cells and in pre-BCR triggering. Proc Natl Acad Sci USA 2002; 99: 13014-13019.
14. Yang M, Hase H, Legarda-Addison D, Varughese L, Seed B, Ting AT. B cell maturation antigen, the receptor for a proliferation-inducing ligand and B cell-activating factor of the TNF family, induces antigen presentation in B cells. J Immunol 2005; 175: 2814-2824. (Pubitemid 41170498)
15. Zucchetto A, Benedetti D, Tripodo C, Bomben R, Dal Bo M, Marconi D et al. CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival. Cancer Res 2009; 69: 4001-4009.